Dr. David Samadi, world-renown celebrity doctor says recent studies have linked prostate cancer to obesity. Scientists have discovered that in overweight patients, more aggressive forms of cancer occur, and Dr. David Samadi says the speed at which people gain weight can also influence the progression of the disease.
Researchers have documented trends among patients gaining weight: Obese men with a BMI of more than 30 had a significantly increased risk of recurrence of prostate cancer. This risk was even higher in patients who were overweight by the age of 40 years. These findings support the hypothesis that the development of aggressive forms of prostate cancer is influenced by environmental factors that occur early in life. In a recent interview, published on prostatecancer911, Dr. Samadi discussed how insulin may be a determining factor in slowing down the aggressiveness of the disease. The doctor also points out how lifestyle choices can help diminish the risk of prostate cancer.
Experts have said that dietary recommendations for the prevention of diabetes and heart disease may also reduce prostate cancer mortality. Mediterranean countries only have between one and a half and two percent of men who are diagnosed with prostate cancer. It is also known that prostate cancer strikes more often than not in those countries in which meat is the main entree. Prostate cancer is much rarer in Asian countries. In Japan, there are ten times fewer people that are diagnosed with prostate cancer than in the United States. It is believed that this is mainly because the Japanese has a diet with lots of fish and vegetables.
The increased risk of prostate cancer due to obesity and altered metabolic levels may be due to the relationship between obesity and insulin resistance and high insulin levels, says Dr. David Samadi. Thus one of the reasons the doctor recommends a healthier lifestyle that includes maintaining a healthy weight.
Dr. David Samadi is a leading New York City urologist, who received his Bachelor of Arts degree in Biochemistry and Medical Degree at Stony Brook University, New York. He completed his internship and his urologic residency at New York’s Montefiore Hospital and Albert Einstein Hospital, and is currently Chief of Robotic Surgery at Lenox Hill Hospital.